Atreyi Dasgupta

Learn More
Glioma stem-like cells (GSCs) may be the initiating cells in glioblastoma (GBM) and contribute to the resistance of these tumors to conventional therapies. Development of novel chemotherapeutic agents and treatment approaches against GBM, especially those specifically targeting GSCs are thus necessary. In the present study, we found that a novel Janus(More)
Metformin, a diabetes drug with well-established side effect and safety profiles, has been widely studied for its anti-tumor activities in a number of cancers, including breast cancer. But its mechanism of action in the clinical arena remains elusive. In a window of opportunity trial of metformin in non-diabetic breast cancer patients, Dowling and(More)
Apoptosis, and the more recently discovered necroptosis, are two avenues of programmed cell death. Cancer cells survive by evading these two programs, driven by oncogenes and tumor suppressor genes. While traditional therapy using small molecular inhibitors and chemotherapy are continuously being utilized, a new and exciting approach is actively underway by(More)
It was once thought that menopause is the result of exhaustion of ovarian follicles. However, it is now known that complex interplay of neurohormonal and ovarian signals heralds the onset of menopause and hypothalamus plays an important role. Increasing dysfunction of these neurohormonal and ovarian factors with aging ultimately leads to reproductive(More)
  • 1